Key facts
- ThinkMD’s last known valuation is $18.0M (Oct 2021).
- It has raised $8.8M across 6 recorded rounds; the latest was Seed Round ($4.0M) in Oct 2021.
- Notable investors include MassChallenge, Village Capital, Sorenson Impact Foundation, Johnson & Johnson Services, Social Venture Circle — 14 tracked in total.
- ThinkMD has filed 9 Form Ds with the SEC since 2015, most recently Oct 2021 ($4.0M sold to 14 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for ThinkMD
Funding rounds
6 roundsAbout ThinkMD
Developer of clinical intelligence software designed to diagnose and treat patients at the clinic or community level. The company's software helps healthcare professionals understand what the data means and track performance, enabling physicians to increase healthcare capacity, evolve healthcare delivery and collect and analyze critical public health data that will improve clinical outcomes, surveillance and healthcare management globally.
- Sector
- Healthcare
- HQ
- Burlington, VT, United States
- Founded
- 2014
- Employees
- 15
- Website
- thinkmd.ai/
- Ownership
- Privately Held (backing)
ThinkMD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ThinkMD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ThinkMD in its N-PORT filings yet. We sweep new filings monthly.